Abstract
A subset of upper urinary tract urothelial cell carcinomas (UUC), arising sporadically or as a manifestation of hereditary non-polyposis colorectal cancer, displays microsatellite instability (MSI). MSI tumours are characterized by defective mismatch repair and accumulation of frameshift mutations in numerous genes harbouring repeats in their coding sequences. We have evaluated the incidence of MSI in UUC and the intratumoral distribution of mutations in 13 candidate target genes. A total of 58 unselected UUC were screened for MSI using the panel of five mononucleotide markers recently recommended by the National Cancer Institute for a precise MSI assessment. Four tumours displayed MSI (7%), among which at least three had alterations in the genes MSH3, BAX, MRE11, RAD50. Mutations in genes involved in key cellular pathways (ATR, DNA-PKcs, MBD4, TCF-4, MSH6, and BLM) were further detected. BAX and MRE11 mutations tend to present homogeneously within the three MSI UUC. Immunohistochemistry (MLH1, MSH2, MSH6) showed that loss of mismatch repair protein expression occurred in all MSI UUC defining the gene defect and that MRE11 and RAD50 mutations were associated with their concomitant loss expression. In conclusion, MSI UUC represent a small proportion of UUC in which BAX and MRE11 mutations are frequent and may play a role early in UUC tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A et al. (1999). Int J Cancer 81: 214–218.
Abdel-Rahman WM, Georgiades IB, Curtis LJ, Arends MJ, Wyllie AH . (1999). Oncogene 18: 2139–2142.
Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA . (2002). Int J Cancer 98: 274–278.
Barnetson R, Jass J, Tse R, Eckstein R, Robinson B, Schnitzler M . (2000). Genes Chromosomes Cancer 29: 130–136.
Blaszyk H, Wang L, Dietmaier W, Hofstadter F, Burgart LJ, Cheville JC et al. (2002). Mod Pathol 15: 790–797.
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW et al. (1998). Cancer Res 58: 5248–5257.
Brennetot C, Buhard O, Jourdan F, Flejou JF, Duval A, Hamelin R . (2005). Int J Cancer 113: 446–450.
Buhard O, Suraweera N, Lectard A, Duval A, Hamelin R . (2004). Dis Markers 20: 251–257.
Catto JW, Azzouzi AR, Amira N, Rehman I, Feeley KM, Cross SS et al. (2003). Oncogene 22: 8699–8706.
Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J . (1997). Cancer Res 57: 4749–4756.
Duval A, Hamelin R . (2002). Cancer Res 62: 2447–2454.
Duval A, Reperant M, Compoint A, Seruca R, Ranzani GN, Iacopetta B et al. (2002). Cancer Res 62: 1609–1612.
Epstein JI, Amin MB, Reuter VR, Mostofi FK . (1998). Am J Surg Pathol 22: 1435–1448.
Ericson KM, Isinger AP, Isfoss BL, Nilbert MC . (2005). BMC Cancer 5: 23.
Giannini G, Rinaldi C, Ristori E, Ambrosini MI, Cerignoli F, Viel A et al. (2004). Oncogene 23: 2640–2647.
Giannini G, Ristori E, Cerignoli F, Rinaldi C, Zani M, Viel A et al. (2002). EMBO Rep 3: 248–254.
Hartmann A, Dietmaier W, Hofstadter F, Burgart LJ, Cheville JC, Blaszyk H . (2003). Hum Pathol 34: 222–227.
Hartmann A, Zanardo L, Bocker-Edmonston T, Blaszyk H, Dietmaier W, Stoehr R et al. (2002). Cancer Res 62: 6796–6802.
Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP et al. (1998). Proc Natl Acad Sci USA 95: 6870–6875.
Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M . (2000). Proc Natl Acad Sci USA 97: 10872–10877.
Jacob S, Miquel C, Sarasin A, Praz F . (2005). Nucleic Acids Res 33: 106–113.
Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H et al. (1997). Cancer Res 57: 808–811.
Kim NG, Choi YR, Baek MJ, Kim YH, Kang H, Kim NK et al. (2001). Cancer Res 61: 36–38.
Ottini L, Falchetti M, Saieva C, De Marco M, Masala G, Zanna I et al. (2004). Carcinogenesis 25: 2337–2343.
Parc Y, Gueroult S, Mourra N, Serfaty L, Flejou JF, Tiret E et al. (2004). Gut 53: 371–375.
Peltomäki P, Vasen HF . (1997). Gastroenterology 113: 1146–1158.
Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC et al. (1997). Science 275: 967–969.
Roupret M, Catto J, Coulet F, Azzouzi AR, Amira N, Karmouni T et al. (2004). J Med Genet 41: e91.
Sijmons RH, Kiemeney LA, Witjes JA, Vasen HF . (1998). J Urol 160: 466–470.
Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, Leroy K et al. (2002). Gastroenterology 123: 1804–1811.
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J et al. (2004). J Natl Cancer Inst 96: 261–268.
Vasen HF, Watson P, Mecklin JP, Lynch HT . (1999). Gastroenterology 116: 1453–1456.
Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G et al. (1996). Gastroenterology 110: 1020–1027.
Verma L, Kane MF, Brassett C, Schmeits J, Evans DG, Kolodner RD et al. (1999). J Med Genet 36: 678–682.
Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J et al. (1995). J Biol Chem 270: 22044–22049.
Woerner SM, Benner A, Sutter C, Schiller M, Yuan YP, Keller G et al. (2003). Oncogene 22: 2226–2235.
Acknowledgements
We thank Dr Alex Duval for helpful discussions, Michèle Oliveiro and Sandrine Villeboux for their expert technical assistance. We also thank Professor Jean-François Fléjou for performing immunohistochemical analyses of mismatch repair proteins. Pierre Mongiat-Artus received support from the ‘Association Française d’Urologie’. Catherine Miquel was supported by the ‘Fondation pour la Recherche Médicale’. This research was supported by a grant from the ‘Association pour la Recherche sur le Cancer’ (No. 4683 to FP)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mongiat-Artus, P., Miquel, C., Van der Aa, M. et al. Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract. Oncogene 25, 2113–2118 (2006). https://doi.org/10.1038/sj.onc.1209229
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209229
Keywords
This article is cited by
-
Comparison of universal screening in major lynch-associated tumors: a systematic review of literature
Familial Cancer (2022)
-
Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome
Modern Pathology (2017)
-
Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications
Cellular Oncology (2011)
-
MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea
British Journal of Cancer (2009)
-
Bladder cancer SNP panel predicts susceptibility and survival
Human Genetics (2009)